Effectiveness of mRNA vaccines against the Alpha and Beta variants in France

In a new study, scientists show that the two-dose vaccination regimen of mRNA vaccines provides 88 percent protection against non-variant virus, 86 percent against the Alpha variant, and 77 percent against the Beta variant.
Read Original Article: Effectiveness of mRNA vaccines against the Alpha and Beta variants in France »